Author Question: How do researchers handle instances in which participants are not legally able to provide their ... (Read 17 times)

sabina

  • Hero Member
  • *****
  • Posts: 563
How do researchers handle instances in which participants are not legally able to provide their informed consent?
 
  a. the requirement for informed consent is waived in such instances
   b. consent is obtained from the participant's parent or legal guardian
  c. the researcher explains the study to the participant verbally in the presence of a witness
  d. such participants can not be used in research
  e. the researcher uses his or her judgment

Question 2

The principle of informed consent requires that participants be told
 
  a. everything abut the study
  b. about the hypotheses of the study, but not about the procedure
  c. everything about the purpose and procedure of the study, but not about the hypotheses.
   d. about aspects of the study that might influence their willingness to participate
   e. only about things that they ask about explicitly



orangecrush

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

B

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

A good example of polar molecules can be understood when trying to make a cake. If water and oil are required, they will not mix together. If you put them into a measuring cup, the oil will rise to the top while the water remains on the bottom.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library